Immune Cell Infiltration (Macrophage and Lymphocyte) in Cystic versus Solid Vestibular Schwannoma.

• Vítor Gonçalves,
• Rui Vaz,
• Elisa-Maria Suhm,
• Vanessa Ries,
• Marco Skardelly,
• Ghazaleh Tabatabai,
• Marcos Tatagiba,
• Jens Schittenhelm,
• Felix Behling

Affiliations

Vítor Gonçalves

Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Faculty of Medicine, University of Porto , Porto, Portugal

Rui Vaz

Faculty of Medicine, University of Porto , Porto, Portugal

Elisa-Maria Suhm

Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen -Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany

Vanessa Ries

Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen -Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany

Marco Skardelly

Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen -Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany

Ghazaleh Tabatabai

Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen -Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Hertie Institute for Clinical Brain Research, Tübingen, Germany; German Cancer Consortium, DKFZ Partner Site Tübingen, Tübingen, Germany

Marcos Tatagiba

Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen -Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany

Jens Schittenhelm

Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen -Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany

Felix Behling

Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen -Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany